Author:
Mick Eric,McManus David D.,Goldberg Robert J.
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference49 articles.
1. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder;Adler;J. Clin. Psychiatry,2008
2. Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder;Adler;J. Clin. Psychiatry,2009
3. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study;Adler;J. Clin. Psychopharmacol.,2009
4. Attention deficit hyperactivity disorder among children aged 5–17 years in the United States, 1998–2009;Akinbami;NCHS Data Brief,2011
5. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm;Biederman;J. Psychiatr. Res,2012
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献